We thank Ann Usher1 for the World Report about the independent external evaluation
of the Access to Covid-19 Tools Accelerator (ACT-A).2 We agree that the findings show
ACT-A did not deliver fully–that was evident given inequities in vaccine coverage
and access to diagnostics and therapeutics. However, the evaluation demonstrated that
stakeholders were satisfied with ACT-A. Most government representatives from low-income
and lower-middle-income countries (LMICs) reported that ACT-A s mandate was very relevant
to them, and the partnership facilitated an unprecedented level of coordination and
collaboration between global health agencies, enabling a rapid response to address
the COVID-19 pandemic.